Race-Specific Genetic Profiles of Homologous Recombination Deficiency in Multiple Cancers

Homologous recombination deficiency (HRD) has been used to predict both cancer prognosis and the response to DNA-damaging therapies in many cancer types. HRD has diverse manifestations in different cancers and even in different populations. Many screening strategies have been designed for detecting...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsiao, Yi-Wen, Lu, Tzu-Pin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8705317/
https://www.ncbi.nlm.nih.gov/pubmed/34945758
http://dx.doi.org/10.3390/jpm11121287

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8705317/
https://www.ncbi.nlm.nih.gov/pubmed/34945758
http://dx.doi.org/10.3390/jpm11121287

Ejemplares similares